Cano Health, Inc. CANO
We take great care to ensure that the data presented and summarized in this overview for Cano Health, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding CANO
View all-
Innovis Asset Management LLC Chicago, IL318KShares$76,3460.03% of portfolio
-
Lloyd Park, LLC Wilmette, IL94.8KShares$22,7411.01% of portfolio
-
Intercontinental Wealth Advisors, LLC58KShares$13,9200.02% of portfolio
-
Pictet Asset Management Sa Geneva 73, V811.9KShares$2,8630.0% of portfolio
-
American Portfolios Advisors Holbrook, NY800Shares$1920.0% of portfolio
-
Trustcore Financial Services, LLC500Shares$1200.0% of portfolio
Latest Institutional Activity in CANO
Top Purchases
Top Sells
About CANO
Cano Health, Inc. provides primary care medical services to its members in the United States and Puerto Rico. It owns and operates medical centers enabled by CanoPanorama, a proprietary population health management technology-powered platform that provides the healthcare providers at its medical centers with a 360-degree view of their members with actionable insights to improve care decisions and member engagement. The company also operates pharmacies, as well as provides dental services in its medical centers. As of December 31, 2021, it operated 130 owned medical centers and approximately 1000 affiliate providers serving approximately 227,005 members. Cano Health, Inc. was founded in 2009 and is headquartered in Miami, Florida.
Insider Transactions at CANO
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Feb 01
2024
|
Elliot Cooperstone |
SELL
Open market or private sale
|
Indirect |
1,100
-0.21%
|
$2,200
$2.53 P/Share
|
Jan 31
2024
|
Elliot Cooperstone |
SELL
Open market or private sale
|
Indirect |
8,935
-1.7%
|
$17,870
$2.59 P/Share
|
Jan 30
2024
|
Elliot Cooperstone |
SELL
Open market or private sale
|
Indirect |
12,703
-2.36%
|
$25,406
$2.7 P/Share
|
Jan 29
2024
|
Elliot Cooperstone |
SELL
Open market or private sale
|
Indirect |
41,357
-7.13%
|
$82,714
$2.74 P/Share
|
Jan 26
2024
|
Elliot Cooperstone |
SELL
Open market or private sale
|
Indirect |
32,693
-5.34%
|
$65,386
$2.74 P/Share
|
Jan 25
2024
|
Elliot Cooperstone |
SELL
Open market or private sale
|
Indirect |
18,569
-2.94%
|
$37,138
$2.58 P/Share
|
Jan 24
2024
|
Elliot Cooperstone |
SELL
Open market or private sale
|
Indirect |
35,808
-5.37%
|
$71,616
$2.84 P/Share
|
Jan 23
2024
|
Elliot Cooperstone |
SELL
Open market or private sale
|
Indirect |
73,034
-9.87%
|
$146,068
$2.94 P/Share
|
Jan 22
2024
|
Elliot Cooperstone |
SELL
Open market or private sale
|
Indirect |
125,000
-14.45%
|
$250,000
$2.5 P/Share
|
Jan 18
2024
|
Elliot Cooperstone |
SELL
Open market or private sale
|
Indirect |
100,000
-10.36%
|
$100,000
$1.91 P/Share
|
Jan 17
2024
|
Elliot Cooperstone |
SELL
Open market or private sale
|
Indirect |
100,000
-4.72%
|
$200,000
$2.6 P/Share
|
Jan 12
2024
|
Elliot Cooperstone |
BUY
Conversion of derivative security
|
Indirect |
1,065,206
+50.0%
|
-
|
Jan 12
2024
|
Elliot Cooperstone |
SELL
Open market or private sale
|
Indirect |
24,171
-100.0%
|
$72,513
$3.3 P/Share
|
Jan 11
2024
|
Elliot Cooperstone |
SELL
Open market or private sale
|
Indirect |
25,000
-50.84%
|
$75,000
$3.59 P/Share
|
Jan 10
2024
|
Elliot Cooperstone |
SELL
Open market or private sale
|
Indirect |
25,000
-33.71%
|
$75,000
$3.73 P/Share
|
Jan 09
2024
|
Elliot Cooperstone |
SELL
Open market or private sale
|
Indirect |
25,000
-25.21%
|
$75,000
$3.75 P/Share
|
Jan 08
2024
|
Elliot Cooperstone |
SELL
Open market or private sale
|
Indirect |
25,000
-20.13%
|
$75,000
$3.82 P/Share
|
Jan 05
2024
|
Elliot Cooperstone |
SELL
Open market or private sale
|
Indirect |
25,000
-16.76%
|
$75,000
$3.85 P/Share
|
Jan 04
2024
|
Elliot Cooperstone |
SELL
Open market or private sale
|
Indirect |
13,328
-8.2%
|
$53,312
$4.0 P/Share
|
Jan 03
2024
|
Elliot Cooperstone |
SELL
Open market or private sale
|
Indirect |
75,000
-17.18%
|
$300,000
$4.51 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 4.07M shares |
---|---|
Conversion of derivative security | 2.35M shares |
Bona fide gift | 600K shares |
Open market or private sale | 2.94M shares |
---|---|
Bona fide gift | 600K shares |